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ABSTRACT
The Kru ¨ppel-like zinc finger protein Gli-similar 3
(Glis3) plays a critical role in pancreatic develop-
ment and has been implicated in a syndrome with
neonatal diabetes and hypothyroidism (NDH). In this
study, we examine three steps critical in the
mechanism of the transcriptional regulation by
Glis3: its translocation to the nucleus, DNA binding
and transcriptional activity. We demonstrate that
the putative bipartite nuclear localization signal
is not required, but the tetrahedral configuration
of the fourth zinc finger is essential for the
nuclear localization of Glis3. We identify (G/C)
TGGGGGGT(A/C) as the consensus sequence of
the optimal, high-affinity Glis3 DNA-binding site
(Glis-BS). All five zinc finger motifs are critical for
efficient binding of Glis3 to Glis-BS. We show that
Glis3 functions as a potent inducer of (Glis-BS)-
dependent transcription and contains a transactiva-
tion function at its C-terminus. A mutation in Glis3
observed in NDH1 patients results in a frameshift
mutation and a C-terminal truncated Glis3. We
demonstrate that this truncation does not effect
the nuclear localization but results in the loss of
Glis3 transactivating activity. The loss in Glis3
transactivating function may be responsible for the
abnormalities observed in NDH1.
INTRODUCTION
Gli-similar (Glis) 1–3 constitute a subfamily of Kru ¨ ppel-
like zinc proteins that are related to members of the Gli
and Zic family (1–6). These proteins share a highly
conserved zinc ﬁnger domain consisting of ﬁve Cys2His2-
type zinc ﬁnger motifs; however, they exhibit little
homology outside their zinc ﬁnger domains. Gli and Zic
proteins mediate their transcriptional regulation by
binding to speciﬁc DNA elements, referred to as
Gli-binding sites (GBS), in the promoter region of target
genes (7,8).
During embryonic development Glis1–3 genes are
expressed in a spatial and temporal manner and play a
critical role in the regulation of several physiological
processes (1–6,9). Glis1 is highly expressed in dermal
papilla cells in the skin and is highly induced in the
epidermis of psoriatic patients (10). Glis2 is expressed in
the cranial and dorsal ganglia, neural tube and in the
intermediate zone of the hindbrain in E9.5 mouse embryos
(6). Recent studies showed that loss of Glis2 expression
causes nephronophthisis, an autosomal recessive kidney
disease and the most frequent genetic cause for end-stage
renal failure in humans (11,12). Moreover, Glis2 has been
implicated in the regulation of neuronal diﬀerentiation (3).
Glis3 is highly expressed in the metanephric mesenchyme
during embryonic development and in the uterus, pan-
creas and kidney of adult mice (9). Glis3 was shown to
enhance osteoblast diﬀerentiation by inducing the expres-
sion of FGF18 (13). A recent study linked mutations in
Glis3 to a human syndrome consisting of neonatal
diabetes and congenital hypothyroidism (NDH) (14).
NDH1-type patients exhibit the most severe eﬀects and
die between 10 days and 2 years after birth. These patients
show a number of pathologies, including diabetes,
polycystic kidney disease, glaucoma, hyperthyroidism,
facial dysmorphology and liver ﬁbrosis suggesting that
Glis3 plays a critical role in the regulation of pancreatic
development and in several other tissues.
Glis proteins control these physiological processes by
regulating the transcription of speciﬁc genes in these target
tissues. Changes in the function or activity of Glis3
proteins result in alterations in gene expression and,
subsequently, abnormalities in cell and tissue functions.
However, relatively little is known about the mechanisms
by which Glis proteins regulate gene expression. Although
Glis proteins have been reported to bind the GBS
consensus (1–6), the sequence of their optimal DNA-
binding site has not yet been determined.
To obtain greater insight into the physiological func-
tions of Glis3 and its role in diseases, including NDH, it is
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steps involved in the transcriptional regulation by Glis3,
including its translocation to the nucleus, its interaction
with speciﬁc DNA-binding sites and transcriptional
activation through its activation domain. The objective
of this study is to gain further insight into these three
critical steps. We demonstrate that not the putative
bipartite nuclear localization signal (bNLS) but ZF4 of
Glis3 is required for its nuclear translocation. In addition,
we deﬁne for the ﬁrst time the consensus sequence of the
optimal DNA-binding site of Glis3 (Glis-BS) and show
that all ﬁve individual zinc ﬁnger motifs are required for
optimal binding. Moreover, we show that the full-length
Glis3 functions as an activator of transcription and that
the activation domain resides at its C-terminus. We
demonstrate that Glis3(NDH1), a C-terminal-truncated
Glis3 associated with NDH1 patients, still localized to the
nucleus but lost its transactivation function. This loss may
be responsible for the abnormalities observed in NDH1
patients. Our study provides greater insight into the
diﬀerent steps required for the transcriptional regulation
by Glis3 and will help in understanding its function in the
regulation of pancreatic development and renal functions
and its role in NDH.
MATERIALS AND METHODS
Plasmids
The reporter plasmid p(Glis-BS)6-LUC containing six
copies of the consensus Glis-BS sequence, was generated
by cloning two copies of 50-CGTGGGGGGTCATGACA
TGTGGGGGGTCATGACATGTGGGGGGTCTCGA,
containing three (Glis-BS) elements into pCRII-TOPO
(Invitrogen, Carlsbad, CA, USA) and its subsequent
insertion into the KpnI and BglII restriction sites of the
luciferase reporter plasmid pTAL-LUC (Clontech, Palo
Alto, CA, USA). The reporter plasmid p(Glis-BSmut)6-
LUC was generated in the same way using 50-CGTG
GGAGGTCATGACATGTGGGAGGTCATGACATG
TGGGAGGTCTCGA.
Transactivation, immuno-pulldown and quantitative
real-time RT-PCR analysis
Electrophoretic mobility shift assay (EMSA) was carried
out as described previously (15). EMSA, transactivation,
and quantitative real-time RT-PCR (QRT-PCR) analyses
are described in detail in Supplementary Data.
Selection ofGlis3-binding sites
The consensus DNA-binding site of Glis3 was determined
by a procedure similar to that reported previously (15).
A mixture of 60bp double-stranded DNA fragments was
synthesized by PCR using the random oligomer 50-CG
AATTCGCTCAGCT-N22-GTACTGCAGGATCCA as
template and 50-CGAATTCGCTCAGCT-30 (primer 1)
and 50-TGGATCCTGCAGTAC-30 (primer 2) as the
forward and reverse primers, respectively. PCR ampliﬁca-
tion was carried out using 20pmol of oligomer, 100pmol
of
32P-end-labeled forward primer and 100pmol of reverse
primer for three cycles under the following conditions:
1min at 948C, 1min at 558C and 1min at 728C for each
cycle. The double-stranded mixed DNA fragments gener-
ated were puriﬁed, incubated with Glis3(ZFD) protein
and complexes analyzed by EMSA. A band corresponding
to the Glis3/Glis-BS complex was excised and the DNA
eluted in TE buﬀer. Recovered DNA was ampliﬁed by
PCR for 15 cycles and used for another round of EMSA
analysis as described above. This procedure was repeated
ﬁve times. In the sixth round, PCR products were cloned
into pCRII-TOPO (Invitrogen). The inserts from individ-
ual white colonies were ampliﬁed and used for EMSA with
Glis3(ZFD). The ampliﬁed DNA inserts that bound
Glis3(ZFD) as indicated by EMSA were subjected to
sequence analysis. The sequences of 36 independent clones
were analyzed.
Confocal microscopy
HEK293T cells were plated in glass bottom culture dishes
(Mattek Corp., Ashland, MA, USA) and the next day
transfected with various p3 FLAG-CMV-Glis3 plasmids.
After an additional 24h incubation, cells were ﬁxed in
4% paraformaldehyde followed by treatment with 0.2%
Triton X-100 for 7min. Cells were washed in PBS and
subsequently incubated for 15min in 1% BSA, then for
2h with anti-FLAG M2 mouse monoclonal antibody
(Sigma), and ﬁnally for 40min with goat anti-mouse
Alexa Fluor594 antibody (Molecular Probes, Eugene, OR,
USA). Cells were washed with PBS and nuclei stained with
40-6-diamidino-2-phenylindole (DAPI). Alternatively,
cells were transfected with pEGFP-Glis3 or pEGFP-
Glis3(ZF)1–5m. Fluorescence was observed 24h later in
a Zeiss confocal microscope LSM 510 NLO (Zeiss,
Thornwood, NY, USA).
Electrophoretic Mobility Shift Assay
Escherichia coli BL21 (DE3) transformed with pQE32-
Glis3(ZFD), pQE32-Glis3(ZFD) mutants and pQE32-
Gli1(ZFD) were grown at 378C to mid-log phase and then
treated with isopropyl-b-D-thiogalactopyranoside (0.5mM
ﬁnal concentration) for 3h. (His)6-tagged proteins were
puriﬁed using Ni-NTA
+ resin (Qiagen) or Talon magnetic
beads (Clontech). (His)6-tagged Glis3(ZFD) was further
puriﬁed by FPLC using a S-200 column (Supplementary
Figure 1S). For EMSA (His)6-Glis3(ZFD) (2.0mgo ra s
indicated otherwise) was incubated with
32P-labeled,
double-stranded oligonucleotides (0.4nM or as indicated
otherwise) in binding buﬀer (20mM Hepes, pH 8.0,
5% glycerol, 2.5mM MgCl2, 1mM DTT, 50mM KCl,
10mM ZnSO4, 300mg poly(dI-dC) for 30min at room
temperature (15). The protein–DNA complexes were
separated on a 10% native polyacrylamide gel (Hoefer
18 16cm
2) and visualized by autoradiography. Bound
and free Glis-BS was measured using a Fluoskan 8900
densitometer (Alpha Innotech, San Leandro, CA, USA).
Equilibrium dissociation constant (Kd) values were calcu-
lated from a Hill function ﬁt to the bound and total
concentration data.
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Identification and expression of alonger variant
ofmouse Glis3
Comparison of the mouse Glis3 sequence (9) with
sequences in Genbank identiﬁed a mouse sequence
(AK054020) that was identical to Glis3 but extended the
coding region another 465nt towards the 50-end. This
sequence encoded a variant of Glis3 that is 155 amino
acids longer at the amino-terminus. The nucleotide and
deduced amino acid sequences of the extended region of
this variant are shown in Figure 1A. In this study, we will
refer to the full-length Glis3 and its shorter variant as
Glis3 and Glis3(N155), respectively. The open reading
frame of Glis3 sequence encodes a protein of 935 amino
acids with a calculated mass of 99.7kDa and pI of 8.73.
Pattern/proﬁle searches did not reveal the presence of any
speciﬁc motif in the extended 155 amino acid amino-
terminus. QRT-PCR analysis with primers that speciﬁ-
cally amplify a 50 region of Glis3, demonstrated that the
Figure 1. (A) Nucleotide and amino acid sequence of Glis3. The new extended N-terminal sequence of Glis3 is indicated in bold; only the 50-end of
Glis3 is shown. The start codons are underlined; the ﬁrst start codon belongs to full-length Glis3, the second one to the previously reported
Glis3(N155) (9). A schematic view of Glis3 is shown below the sequence. ZFD indicates zinc ﬁnger domain. (B) Expression of full-length Glis3
mRNA in several mouse tissues. Total RNA isolated from various adult tissues was examined by real time QRT-PCR analysis using primers speciﬁc
for the 50-UTR of full-length Glis3. (C) The full-length Glis3 localizes to the nucleus. p3 FLAG-CMV-Glis3 plasmid was transfected in C3H10T1/2
cells and after 48h incubation proteins were isolated and examined by western blot analysis using anti-FLAG M2 antibody. Subcellular localization
of FLAG-Glis3 was examined by confocal microscopy with anti-FLAG M2 and Alexa Fluor 594 antibodies; nuclei were identiﬁed by DAPI staining.
1692 Nucleic Acids Research, 2008, Vol. 36, No. 5longer transcript was expressed in several tissues analyzed
(Figure 1B) and was most highly expressed in kidney as
reported previously for Glis3(N155) expression (9).
The fourth ZFplays acritical role inthe nuclear
localization of Glis3
Translocation of Glis3 to the nucleus is necessary to
enable it to regulate transcription. To investigate the
subcellular localization of Glis3, murine pluripotent
mesenchymal C3H10T1/2 cells were transfected with an
expression vector encoding 3 FLAG-Glis3. The expres-
sion of Glis3 in C3H10T1/2 cells was ﬁrst examined by
western blot analysis. As shown in Figure 1C, the anti-
FLAG antibody recognized a protein of the expected size.
Analysis of the subcellular localization of Glis3 by
confocal microscopy showed that Glis3 was localized
predominantly to the nucleus (Figure 1C). Glis3 was
localized to the nucleus in >95% of the cells in which
Glis3 was detected. Similar results were obtained in CV-1
and HEK293 cells (data not shown). To determine what
region is required for its nuclear localization, we examined
the Glis3 sequence for the presence of potential nuclear
localization signals using pattern/motif analysis. This
analysis identiﬁed a potential bipartite nuclear localization
signal (bNLS) between Arg
645 and Lys
661, a region that
overlaps with ZF5 (Figure 2A). To determine whether this
bNLS is required for the nuclear localization of Glis3, we
examined the eﬀect of several deletions within the bNLS
on its nuclear localization in HEK293 cells. Deletion of
the C-terminus up to Lys
661, just up to the bNLS, did not
aﬀect the nuclear localization of Glis3. Further C-terminal
deletions up to Ser
652 and Lys
646, which delete large
portions of the bNLS, also did not aﬀect the nuclear
localization of Glis3. These data suggested that the bNLS
is not required for the nuclear localization of Glis3 but
that a diﬀerent region of Glis3 is involved. In addition,
deletion of the N-terminus up to Lys
462 also did not aﬀect
the nuclear localization (Figure 2A). These data suggested
a role for the zinc ﬁnger domain, rather than the N- and
C-terminal regions, in the nuclear localization of Glis3.
We, therefore, examined the eﬀect of a Cys/Ala mutation
within each single zinc ﬁnger on the subcellular localiza-
tion of Glis3. The ﬁrst Cys in each single Cys2His2-type
zinc ﬁnger motif was mutated thereby destroying their
tetrahydral conﬁguration. As shown in Figure 2B, a
mutation in either ZF1, ZF2, ZF3 or ZF5 did not aﬀect
the nuclear localization of Glis3 signiﬁcantly. These Glis3
mutants were preferentially localized to the nucleus in
>95% of the cells in which they were expressed. In
contrast, Glis3 containing the mutation in ZF4 was
distributed about equally between cytoplasm and nucleus
in >90% of the cells. These results suggest that the
tetrahedral conﬁguration of ZF4 is critical in the
nuclear localization of Glis3. Analysis of several addi-
tional mutants showed that EGFP-Glis3(532–930),
containing an N-terminal deletion including ZF1 and
EGFP-Glis3(463–624) containing ZF1–4, are still loca-
lized to the nucleus; however, Glis3(463–595) containing
only ZF1–3, was equally distributed between nucleus and
cytoplasm (Figure 3). These data support the critical role
of ZF4 in the nuclear localization of Glis3. The nuclear
localization of Zic3 has been reported to depend on a
bNLS within ZF4 (16). Although the ZF4 of Glis3 does
not contain a bNLS, it has two basic amino acids Arg
614
and Lys
616 in common with the bNLS of Zic3. However,
an Arg
614Gly mutation did not have any eﬀect on the
nuclear localization of Glis3 (Figure 3) suggesting that
Arg
614 is not essential.
Identification of theconsensus DNA-binding sequence
fortheGlis3
After localizing to the nucleus, Glis3 regulates transcrip-
tion by interacting with speciﬁc DNA-binding sites in the
promoter of target genes. Although members of the Gli
and Zic subfamilies can bind the GBS consensus, these
proteins exhibit distinct aﬃnities for diﬀerent binding
sequences (8). Previous studies reported that Glis proteins
can also bind the GBS consensus sequence (2,6,9);
however, the sequence of the optimal Glis-BS has not
been determined. To identify in an unbiased manner the
consensus sequence that binds Glis3 with high aﬃnity, we
used a DNA-binding site selection strategy that is based
on a combination of PCR and EMSA (15). This strategy
used a mixture of 60bp long oligonucleotides that contain
22 random nucleotides ﬂanked on either side by a known
sequence to facilitate PCR ampliﬁcation and subsequent
cloning of the selected DNA sequence. The PCR products
generated after the sixth round were cloned into pCRII-
TOPO. Inserts from individual clones were then analyzed
by EMSA for Glis3(ZFD) binding and the inserts
that bound Glis3(ZFD) strongly were sequenced. The
sequences of 36 independent clones are shown in
Figure 4A. The number of times that A, T, G and C
appear at each position in these sequences was calculated
and from this the Glis-BS consensus sequence was
deduced (Figure 4B). This analysis indicated that Glis3
bound most eﬀectively to a sequence consisting of the
consensus (G/C)TGGGGGGT(A/C) in which the nucleo-
tides shown in bold form the core motif.
EMSA analysis with
32P-labeled consensus Glis-BS
(GTGGGGGGTC) and His6-Glis3(ZFD) conﬁrmed bind-
ing of Glis3(ZFD) to the consensus sequence (Figure 3C).
Addition of unlabeled Glis-BS competed eﬀectively with
32P-Glis-BS for Glis3 binding. The unlabeled GBS
consensus, consisting of CGTGGGTGGTC, also com-
peted for Glis3 binding but less eﬃciently than the Glis-BS
consensus. This was conﬁrmed by experiments comparing
the binding of His6-Glis3(ZFD) to the consensus Glis-BS
or GBS as a function of increasing concentrations of His6-
Glis3(ZFD) (Supplementary Figure 2S). These results are
in agreement with the conclusion that Glis3 exhibits a
much lower aﬃnity for GBS than the Glis-BS consensus
sequence.
To determine the aﬃnity of Glis3 for the consensus
Glis-BS, we examined the binding of His6-Glis3(ZFD)
as a function of increasing concentrations of Glis-BS.
Saturation analysis showed that optimal binding was
reached at concentrations of about 10nM Glis-BS
(Figure 5A). From these data the apparent Kd was
calculated by Scatchard plot analysis. The Kd of the
Nucleic Acids Research, 2008, Vol. 36, No. 5 1693Figure 2. Nuclear localization of Glis3 does not require the putative bNLS but is dependent on ZF4. HEK293T cells were transfected with the
pEGFP-Glis3 plasmid indicated and 30h later examined by confocal microscopy for EGFP and DAPI ﬂuorescence as described in ‘Materials and
Methods’ section. EGFP was equally divided between cytoplasm and nucleus (data not shown). (A) The bNLS is not required for the nuclear
localization of Glis3. Subcellular localization of wild-type (WT) EGFP-Glis3 (a–c), EGFP-Glis3-NLS1m (d–f), EGFP-Glis3-NLS2m (g–i), EGFP-
Glis3-NLS3m (j–l), EGFP-Glis3(463–930) (m–o). A schematic view of each construct is shown on the right. The putative bNLS sequence is shown in
bold. (B) The nuclear localization of Glis3 is dependent on the tetrahedral conﬁguration of ZF4. Subcellular localization of EGFP-Glis3 (a–c),
EGFP-Glis3(ZF)1m (d–f), EGFP-Glis3(ZF)2m (g–i), EGFP-Glis3(ZF)3m (j–l), EGFP-Glis3(ZF)4m (m–o) and EGFP-Glis3(ZF)5m (p–r). A
schematic view of EGFP-Glis3(ZF)1–5m mutants is shown on the right in (C). The ﬁrst Cys in each zinc ﬁnger motif is mutated to Ala causing loss
of the tetrahedral zinc ﬁnger conﬁguration as indicated. (C) Quantitation of the subcellular localization of Glis3 and Glis3 mutants. The percentage
of cells in which Glis3 is largely restricted to the nucleus (N) or about equally distributed between the nucleus and cytoplasm (N+C) was calculated.
‘n’ indicates the number of Glis3 expressing cells counted.
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0.26nM.
To further analyze the binding speciﬁcity of Glis3, we
examined the eﬀect of a series of point mutations in Glis-
BS on Glis3 binding. As shown in Figure 5C, the Glis-BS
mutants M6, M8-M11 and M14 competed well with
radiolabeled Glis-BS for Glis3(ZFD) binding, suggesting
that these changes in nucleotides do not have a major
impact on Glis3(ZFD) binding. The mutants M2, M3, M5
and M7, competed less eﬃciently, while M1 and M4 were
poor competitors. These results were in good agreement
with results obtained from experiments examining the
ability of Glis3(ZFD) to bind
32P-labeled Glis-BS mutants
(Supplementary Figure 3S).
Comparison of Glis3 and Gli1 binding
We next compared the binding of Glis3 to the Glis-BS
consensus, the Glis-BS mutants M2, M3 and M6, and the
GBS consensus with that of Gli1. Our EMSA showed that
both Glis3 and Gli1 bound the consensus Glis-BS more
eﬀectively than GBS (Figure 6A). Moreover, Glis3 bound
moderately well to the M3 mutant while Gli1 did not bind
M3. These observations suggest that although Glis3 and
Gli1 bind similar binding sites, they can exhibit diﬀerent
aﬃnities for distinct sites.
These results also showed that Gli1 bound Glis-BS
more eﬃciently than GBS, which was reported to be
the optimal binding sequence of Gli1. We, therefore,
determined the Kd for the binding of Gli1 to the Glis-BS
consensus by Scatchard plot analysis (Figure 5B). This
analysis indicated that the apparent Kd for the interaction
of Gli1 with Glis-BS was 3.32 1.11nM. These data
demonstrate that both Glis3 and Gli1 exhibit a high and
similar aﬃnity for the consensus Glis-BS.
Next, we compared the ability of VP16-Glis1-3 proteins
to induce (Glis-BS)6-dependent transcriptional activation
of the LUC reporter gene (Glis-BS)6-LUC reporter, in
which the luciferase reporter is under the control of six
consensus Glis3 binding sites. This activation is largely a
reﬂection of the ability of the fusion proteins to bind
Glis-BS. The data in Figure 6B show that VP16-Glis1,
VP16-Glis3 and VP16-Gli1 enhanced (Glis-BS)6-
dependent reporter gene expression 34-, 11- and 23-fold,
respectively. These results are in agreement with the
conclusion that VP16-Glis1, -Glis3 and -Gli1 fusion
proteins eﬀectively bind Glis-BS. VP16-Glis1 and VP16-
Glis3 did not signiﬁcantly induce LUC reporter through
Glis-BSmut (Figure 5B) in agreement with the observation
that Glis3 has low aﬃnity for Glis-BSmut (50-CGTGGT
GGGTC; M13 in Supplementary Figure 3S). In contrast,
VP16-Gli1 was still able to increase LUC transcription
supporting the conclusion that Glis3 and Gli1 have
distinct but overlapping binding speciﬁcities. Similar
results were obtained when this assay was performed
in Chinese hamster ovary (CHO) cells (data not shown).
VP16-Glis2 induced Glis-BS-dependent LUC reporter
Figure 3. Subcellular localization of several Glis3 mutants. HEK293T cells were transfected with pEGFP-Glis3 or a pEGFP-Glis3 mutant as
indicated. The subcellular localization of the fusion proteins was examined 30h later by ﬂuorescent confocal microscopy as described in ‘Materials
and methods’ section. (A) Subcellular localization of EGFP (a–c), EGFP-Glis3(532–930) (d–f), EGFP-Glis3(463–624) (g–i) and EGFP-Glis3(463–595)
(j–l). (B) Subcellular localization of Glis3 and Glis3(R
614G) mutant in HEK293T cells. The sequences of the ﬁve zinc ﬁnger domains are shown
below. (C) Quantitation of the subcellular localization of Glis3 mutants.
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binding or, since Glis2 acts as a repressor, to the presence
of a dominant Glis2 repressor function.
Allfive zinc fingerdomains areimportant in the
bindingof Glis3 to Glis-BS
To examine the role of each individual zinc ﬁnger in the
binding of Glis3(ZFD) to the Glis-BS consensus sequence,
the eﬀect of several mutations on the binding of Glis3 was
determined by EMSA. The ﬁrst Cys in each single
Cys2His2-type zinc ﬁnger motif was mutated resulting in
the loss of their tetrahedral conﬁguration (Figure 7A). As
shown in Figure 7B, a mutation in each single zinc ﬁnger
motif totally abolished binding of Glis3 to the consensus
Glis-BS suggesting that the tetrahedral conformation
of each zinc ﬁnger motif is required for optimal binding
of Glis3. This conclusion was supported by analysis of the
activation of (Glis-BS)6-LUC reporter by VP16-Glis3
proteins (Figure 7C). The transcriptional activation by
these fusion proteins is dependent on the binding of VP16-
Glis3 to Glis-BS and the VP16 activation domain. The
data showed that none of the VP16-Glis3 zinc ﬁnger
mutants was able to induce LUC reporter activity
suggesting that they did not bind Glis-BS in agreement
with our EMSA results (Figure 7B and C). The
importance of the ﬁrst and ﬁfth zinc ﬁnger motifs in the
binding of Glis3 to Glis-BS was supported by the analysis
of two additional mutants VP16-Glis3C625, containing
a C-terminal deletion up to ZF4, and VP16-Glis3N532,
containing an N-terminal deletion including ZF1. Both
mutants were unable to induce LUC transcription
(Figure 7D) in agreement with the conclusion that they
do not bind Glis-BS.
Figure 4. Identiﬁcation of the consensus DNA-binding site (Glis-BS). To determine the consensus sequence of the Glis-BS that binds Glis3 with
highest aﬃnity, a DNA-binding site selection strategy was followed that was based on a combination of PCR and EMSA as described in ‘Materials
and Methods’ section. A mixture of 60bp oligonucleotides containing 22 random bases (N22) ﬂanked on each side by a 20bp primer (primer 1 and 2)
was used as template. (A) Sequences of the 22nt long fragments that bind Glis3 with high aﬃnity identiﬁed in 36 independent clones. The Glis-BSs
are indicated in bold. Italic nucleotides are part of the primer sequence. (B) Calculation of the consensus Glis-BS. Top line: numbers indicate the
position of the nucleotide in the Glis-BS. The next four lines indicate the percentages by which G, A, T or C were present at each position. The
bottom line shows the calculated consensus sequence of Glis-BS. The font size relates to the frequency by which the nucleotide is found at each
position. N indicates no strong requirement for a speciﬁc nucleotide. (C) Binding of His6-Glis3(ZFD) (2mg) to the
32P-labeled consensus Glis-BS
(0.5nM) was examined by EMSA in the absence (lane 1) and presence of a 5-, 25- and 50-fold excess of unlabeled consensus Glis-BS (lanes 2–4) or
GBS (lanes 6–8). The sequence of Glis-BS and GBS is shown at the bottom. B, indicates bound Glis-BS or GBS; F, free Glis-BS or GBS.
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The aforementioned results characterized the nuclear
translocation and DNA binding of Glis3, we next
determined whether the full-length Glis3 was able to
activate Glis-BS-dependent transcription and function as
a transcriptional activator. For this purpose HEK293T
cells were transiently transfected with a Glis3 expression
and a (Glis-BS)6-LUC reporter plasmids and the
transcriptional activity of Glis3 analyzed. As shown in
Figure 8, Glis3 induced (Glis-BS)-dependent transcription
32-fold suggesting that it functions as a transcriptional
activator. Glis3(N155) and Glis3(N463) containing
amino-terminal deletions, were almost as active as full-
length Glis3 suggesting that the amino-terminus does not
appear to contain a repressor or activation function.
In contrast, the carboxyl-terminal mutant Glis3(C756)
Figure 5. Analysis of the aﬃnity and speciﬁcity of the binding of Glis3 and Gli1 to Glis-BS. (A) Binding of Glis3 to Glis-BS. The binding of His6-
Glis3(ZFD) to radiolabeled Glis-BS was examined by EMSA as a function of increasing concentrations of Glis-BS as indicated (top panel). The
amount of bound and free Glis-BS was determined and the Kd calculated by Scatchard plot analysis (lower panel). (B) Binding of Gli1 to Glis-BS.
The binding of His6-Gli1(ZFD) to radiolabeled Glis-BS was examined by EMSA as a function of increasing concentrations of Glis-BS as indicated
(top panel). The amount of bound and free Glis-BS was determined and the Kd calculated by Scatchard plot analysis (lower panel). (C) Eﬀect of
various mutations in Glis-BS on Glis3 binding. EMSA analysis was performed with His6-Glis3(ZFD) and the
32P-labeled consensus Glis-BS (0.5nM)
in the absence and presence of 5- or 25-fold excess of unlabeled Glis-BS or mutant Glis-BS (M1-M14) as indicated. The sequences of the M1-M14
mutants are shown beneath the EMSA. The mutated nucleotides are underlined.
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an activation function at the C-terminus.
NDH1mutation results in theloss of Glis3 transactivating
function
A recent genetic study implicated Glis3 in a syndrome
with NDH (14). One family of patients (NDH1) with the
most severe NDH contained a homozygous insertion
(2997insC) leading to a frameshift and a truncated Glis3
protein, referred to as Glis3(NDH1) (Figure 9A). To
examine the eﬀect of this truncation on the subcellular
localization and transcriptional activity of Glis3, we
generated a mutant Glis3(NDH1) expression plasmid
that contains this NDH1 truncation (Figure 9A). As
WT Glis3, Glis3(NDH1) still localized to the nucleus
(Figure 9B). However, in contrast to WT Glis3,
Glis3(NDH1) did not induce Glis-BS-dependent trans-
cription of the LUC reporter in HEK293T (Figure 9C).
These data are in agreement with our obervations that the
transactivating domain is localized at the C-terminus of
Glis3 (Figure 8). Thus, the NDH1 mutation induces loss
of the Glis3 transactivating function. This loss might be
responsible for the abnormalities observed in NDH1
patients.
DISCUSSION
Glis3 is a member of the Glis Kru ¨ ppel-like zinc ﬁnger
subfamily of transcription factors that are related to
members of the Gli and Zic families (5,6,9). In this study,
we describe a sequence that extends the previously
reported mouse Glis3 protein by an additional 155
amino acids (9) at the N-terminus and further characterize
several steps (nuclear localization, DNA binding and
transcriptional activity) that are critical in the mechanism
by which Glis3 regulates transcription. Translocation of
the Glis3 to the nucleus is an essential step in the pathway
by which it regulates transcription. Regulation of nuclear
import and export provides an important mechanism by
which the cell can control the transcriptional activity of
many transcription factors (17). The traﬃcking of Gli and
Zic proteins between cytoplasm and nucleus is controlled
at multiple levels and provides a mechanism to regulate
their transcriptional activity (16,18). And although Gli
and Zic proteins are related, the mechanism involved in
their nucleocytoplasmic traﬃcking are very diﬀerent
(16,19). We show that, in number of cell types, full-
length Glis3 localized preferentially to the nucleus.
Nuclear import and export can occur by passive diﬀusion
of proteins smaller than  40kDa (20) while larger
proteins are translocated by active transport or in complex
with actively transported proteins. Because of its size
(97kDa), the nuclear localization of Glis3 likely involves
an active transport mechanism. The classical import
mechanism involves binding of the importin-a/b hetero-
dimer to a nuclear localization signal consisting of one or
two basic regions thereby targeting it for transport
through nuclear pore complexes. The energy for this
transport is provided by the GTPase Ran (17). Pattern/
motif analysis showed that Glis3 contains one putative
bipartite nuclear localization signal (bNLS) that overlaps
with ZF5. Our data demonstrate that this motif is not
required but that ZF4 is essential for the nuclear
localization of Glis3. These observations suggest that the
nuclear translocation of Glis3 is not mediated by a direct
interaction with importins but by a diﬀerent mechanism.
The nuclear localization of several other proteins,
including Wilm’s tumor 1 (WT1) (21), the nuclear receptor
NR2C1 (22), early growth response 1 (Egr1) (23), human
Snail (24), JAZ (25) and erythroid Kru ¨ ppel-like factor
(EKLF) (26), Zic3 (16) are determined by their zinc
Figure 6. (A) Comparison of the binding speciﬁcity of His6-Glis3(ZFD) and His6-Gli1(ZFD) to
32P-labeled Glis-BS, GBS, and the Glis-BS mutants
M2, M3 and M6. Binding was analyzed by EMSA. (B) Comparison of (Glis-BS)- and (Glis-BSmut)-mediated transcriptional activation by VP16-
Glis1-3 and VP16-Gli1. HEK293T cells were co-transfected with pVP16-Glis1-3 or pVP16-Gli1 (0.1mg), (Glis-BS)6-LUC, (Glis-BSmut)6-LUC and
pCMVb as indicated. After 30h, cells were assayed for luciferase (LUC) and b-galactosidase activity as described in ‘Materials and methods’ section.
The relative LUC reporter activity was calculated and plotted. The sequence of Glis-BSmut is CGTGGTGGGTC (M13 in Supplementary Figure 3S).
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nuclear localization are very diﬀerent between these
proteins. Our data show that the nuclear localization of
Glis3 is dependent on the tertiary structure of ZF4 as has
been reported for Egr1, JAZ and human Snail (23–25). In
contrast, the nuclear localization of EKLF1 is indepen-
dent of the tertiary structure of its zinc ﬁngers (26). The
loss of nuclear retention was not due to the inability of
Glis3 to bind DNA since mutations in other zinc ﬁnger
motifs, which also abolish DNA binding, did not eﬀect
nuclear localization. The nuclear localization of Zic3 has
been reported to depend on a bNLS within ZF4 (16).
Although the ZF4 of Glis3 shows 58% sequence
homology with that of Zic3, this bNLS is not conserved.
Moreover, mutation of Arg
614 within ZF4 into Gly, which
further abolishes this site, did not have any eﬀect on
the nuclear localization of Glis3. Zic3 also contains a
nuclear export signal comprising the second and third
Figure 7. All ﬁve zinc ﬁnger motifs are required for optimal binding of Glis3 to the consensus Glis-BS. (A) A schematic view of His6-Glis3(ZFD)
1–5m mutants in which the ﬁrst Cys in each zinc ﬁnger motif is mutated to Ala (left panel). PAGE analysis of His6-Glis3(ZFD) proteins used
in EMSA (upper panel). (B) EMSA using His6-Glis3(ZFD) and His6-Glis3(ZFD)1–5m mutant proteins and
32P-labeled consensus Glis-BS.
The position of the Glis3/Glis-BS complex is indicated by the arrow. (C) The ability of VP16-Glis3 and VP16-Glis3(ZFD)1–5m mutants to induce
(Glis-BS)6-dependent transactivation of the LUC reporter gene was examined in HEK293T cells. (D) The ability of VP16-Glis3 and mutants
VP16-Glis3(C625) and VP16-Glis3(N532), encoding a C- and N-terminal deletion mutant of Glis3 as indicated in the lower panel, to induce
(Glis-BS)6-dependent transactivation of the LUC reporter gene was examined. The relative luciferase activity was calculated and plotted. Numbers
indicate amount of plasmid (mg) transfected.
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contain any nuclear export signal.
After entering the nucleus, Glis3 functions as a
transcriptional regulator by binding to speciﬁc DNA
elements (Glis-BS) in the promoter of target genes. In this
study, we determined for the ﬁrst time the consensus
sequence required for optimal Glis3 binding using a PCR/
EMSA-based site selection strategy. This strategy identi-
ﬁed 50-(G/C)TGGGGGGT(A/C) as the optimal binding
sequence of Glis3. Glis1, in which ZFD exhibits 93%
sequence homology to that of Glis3, also binds eﬀectively
to the consensus Glis-BS. Analysis of various point
mutations in the Glis-BS consensus on Glis3 binding
conﬁrmed the speciﬁcity of this interaction and showed
that a single nucleotide change in the consensus sequence
can result in the total loss of Glis3 binding. Glis3 binds
with high aﬃnity (an apparent Kd of 3.69 0.26nM) to
the Glis-BS consensus. The consensus Glis-BS shows a
great similarity with the binding sites of Gli and Zic
proteins (7,8,27,28). However, as observed for Gli and Zic
proteins (8), diﬀerences in the binding to distinct DNA-
binding sites were observed between Gli1 and Glis3. Glis3
bound the Glis-BS mutant M3 moderately well while
Gli1 did not bind. Our data also demonstrated that
Glis3 bound Glis-BS more eﬀectively than to the GBS
consensus. Unexpectedly, Gli1 also interacted more
eﬀectively with the Glis-BS than with the GBS consensus
which is considered to be the optimal binding site of Gli1
(7,27). We show that Gli1 exhibited high aﬃnity for the
Glis-BS consensus (an apparent Kd of 3.32 1.11nM)
similar to that of Glis3. The observed overlap in binding
speciﬁcity suggests that Glis and Gli proteins can compete
for binding to the same DNA binding sequence in
the promoter of target genes (9). The latter provide a
mechanism by which the Glis and Gli signaling pathways
might interact or interfere with each other.
To determine the requirements of the interaction of
Glis3 with Glis-BS, we examined the eﬀect of several point
Figure 9. Glis3(NDH1) localized to the nucleus, but lost its transactivation activity. (A) Schematic view of Glis3(155) and Glis3(NDH1). ZDF and
AD are indicated. An insertion of C (arrow head) in the Glis3 gene (NDH1) is linked to the most severe type of NDH. This insertion results in a
frame shift at 779 and a stop codon at 862 (779FS862STOP) as indicated (shaded box). (B) Glis3(NDH1) localizes to the nucleus. HEK293T cells
were transfected with p3 FLAG-CMV-Glis3(NDH1) and subcellular localization was examined by confocal microscopy with anti-FLAG M2 and
Alexa Fluor 594 antibodies; nuclei were identiﬁed by DAPI staining. (C) Glis3(NDH1) lacks transcriptional activity. HEK293T cells were
co-transfected with p3 FLAG-CMV-Glis3(N155), p3 FLAG-CMV-Glis3(NDH1), pCMVb and (Glis-BS)6-LUC as indicated. After 30h, cells
were assayed for luciferase (LUC) and b-galactosidase activity. The relative LUC reporter activity was calculated and plotted. The expression of
Glis3(N155) and Glis3(NDH1) proteins was examined by western blot analysis using anti-FLAG antibody (lower panel).
Figure 8. Full-length Glis3 functions as a potent transcriptional acti-
vator. HEK293T cells were co-transfected with p3 FLAG-CMV-Glis3,
p3 FLAG-CMV-Glis3(N155), p3 FLAG-CMV-Glis3(N463),
p3 FLAG-CMV-Glis3(C756), pCMVb and (Glis-BS)6-LUC as indi-
cated. After 30h, cells were assayed for luciferase (LUC) and
b-galactosidaseactivity. Therelative LUCreporteractivitywascalculated
and plotted. A schematic view of the deletion mutants is shown below the
graph. AD, activation domain; ZDF, zinc ﬁnger domain.
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in each individual zinc ﬁnger motif to alanine, which
demolishes the tetrahedral conﬁguration of the zinc ﬁnger,
destroyed the ability of Glis3 to bind Glis-BS (Figure 7A
and B). These observations indicate that each zinc ﬁnger
motif is critical for the interaction of Glis3 with Glis-BS.
The requirement for ZF1 and ZF5 was supported by the
inability of VP16-Glis3 mutants, lacking ZF1 or ZF5, to
induce (Glis-BS)-dependent transcription (Figure 7C and
D). Previously, crystal structure analysis of Gli1–DNA
complexes and analysis of Gli3 DNA binding have shown
that ZF2-5 bind in the major groove and wrap around the
DNA and that ZF4 and ZF5 make extensive base contacts
(27,29). Although these studies indicated that ZF1 does
not contact the DNA, the inability of ZF1 mutants of
Glis3 to bind Glis-BS suggests that ZF1 might be
important for maintaining the proper structure of the
zinc ﬁnger domain required for optimal Glis3 binding.
This concept is supported by a recent study showing that
mutations within ZF1 of ZIC3 can inﬂuence the nuclear
localization, protein stability, and activity of ZIC3
indicating the importance of ZF1 in ZIC3 activity (30).
After binding Glis-BS, does full-length Glis3 function
as a transcriptional activator? We demonstrated that the
full-length Glis3 induces the transcription of (Glis-BS)6-
dependent reporter suggesting that it functions as a
transcriptional activator. Deletion of a 155- or 463-
amino acid region at the amino-terminus did not aﬀect
the transcriptional activity of Glis3 suggesting that this
region does not appear to contain a repressor or activation
function. In contrast, deletion of the C-terminus totally
abolished the transcriptional activity of Glis3 in agree-
ment with the conclusion that the deleted region contains
an activation domain (9). As reported for other transcrip-
tion factors, transcriptional repression or activation by
Glis proteins is likely mediated through a recruitment of
intermediary proteins that function, respectively, as co-
repressors or co-activators (31). This is supported by
previous ﬁndings showing that C-terminal binding protein
1 (CtBP1) and HDAC3 function as co-repressors of Glis2
(1); however, no co-activators or co-repressors have yet
been identiﬁed for Glis3. In addition to the sequence of the
DNA-binding site and binding aﬃnity, the context of
the binding site within the promoter regulatory region has
been found to be an important determinant in which
transcription factor and intermediary proteins are
recruited to the site (32). This may also apply to the
binding of Gli, Zic and Glis proteins to GBS in target
genes.
Recently, mutations in the Glis3 gene have been
implicated in a syndrome with neonatal diabetes mellitus,
polycystic kidney disease and NDH (14). These studies
have indicated that Glis3 plays a critical role in pancreatic
development and the maintenance of normal kidney
functions. NDH1-type patients exhibit the most severe
eﬀects and die between 10 days and 2 years after birth.
These patients contain a frameshift mutation in the Glis3
gene that yields a truncated Glis3 protein [Glis3(NDH1);
Figure 9A]. In our study, we show that Glis3(NDH1)
still localized to the nucleus but was unable to induce
(Glis-BS)-dependent transactivation. These ﬁndings are
in agreement with our observations (Figure 8) that the
C-terminus of Glis3 contains a transactivation function.
The loss of this transactivation function appears at least in
part responsible for the abnormalities observed in NDH1
patients. However, we cannot rule out that in vivo the
Glis3(NDH1) protein is unstable and rapidly destroyed by
the proteasome system resulting in decreased levels of
Glis3(NDH1) protein.
In summary, in this study we demonstrate that full-
length Glis3 localizes to the nucleus and that its putative
bNLS is not required but that the tetrahedral conﬁgura-
tion of ZF4 is essential for the nuclear localization of
Glis3. These observations suggest that Glis3 is imported
into the nucleus by a nonclassical mechanism. In addition,
we identify the consensus, high aﬃnity Glis-BS sequence
required for optimal Glis3 binding and show that all ﬁve
Glis3 zinc ﬁnger motifs are critical for optimal binding.
We further show that full-length Glis3 functions as a
potent activator of (Glis-BS)-dependent transcription and
contains an activation domain at its C-terminus. This
transactivation function is lost in NDH1 patients and
oﬀers a mechanism explaining the abnormalities observed
in these patients. Our study provides greater insight into
three critical steps involved in the mechanism by which
Glis3 controls transcription. These observations help us to
understand the role of Glis3 in human disease, such as
NDH, and in the regulation of pancreatic development
and renal functions.
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